title: Gemcitabine in arterial injection chemotherapy for pancreatic cancer does not cause catheter obstruction or any other complication.
authors.affiliation: Department of Gastroenterology and Hepatology, Saiseikai Niigata Second Hospital, Teraji 280-7, Niigata 950-1104, Japan. toruishi@ngt.saiseikai.or.jp
authors.forename: Toru
authors.initials: T
authors.lastname: Ishikawa
authors.forename: Kazuo
authors.initials: K
authors.lastname: Higuchi
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Kubota
authors.forename: Kei-ichi
authors.initials: K
authors.lastname: Seki
authors.forename: Terasu
authors.initials: T
authors.lastname: Honma
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Yoshida
authors.forename: Tomoteru
authors.initials: T
authors.lastname: Kamimura
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D057785:Catheters; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004867:Equipment Design; D006801:Humans; D007269:Injections, Intra-Arterial; D008422:Materials Testing; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D013718:Tensile Strength; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine